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Neutrophils kill ingested pathogens by the so-called oxidative burst, where reactive
oxygen species (ROS) are produced in the lumen of phagosomes at very high
rates (mM/s), although these rates can only be maintained for a short period
(minutes). In contrast, dendritic cells produce ROS at much lower rates, but they
can sustain production for much longer after pathogen uptake (hours). It is becoming
increasingly clear that this slow but prolonged ROS production is essential for antigen
cross-presentation to activate cytolytic T cells, and for shaping the repertoire of antigen
fragments for presentation to helper T cells. However, despite this importance of ROS
production by dendritic cells for activation of the adaptive immune system, their actual
ROS production rates have never been quantified. Here, we quantified ROS production
in human monocyte-derived dendritic cells by measuring the oxygen consumption rate
during phagocytosis. Although a large variation in oxygen consumption and phagocytic
capacity was present among individuals and cells, we estimate a ROS production rate of
on average ∼0.5 mM/s per phagosome. Quantitative microscopy approaches showed
that ROS is produced within minutes after pathogen encounter at the nascent phagocytic
cup. H2DCFDA measurements revealed that ROS production is sustained for at least
∼10 h after uptake. While ROS are produced by dendritic cells at an about 10-fold
lower rate than by neutrophils, the net total ROS production is approximately similar.
These are the first quantitative estimates of ROS production by a cell capable of antigen
cross-presentation. Our findings provide a quantitative insight in how ROS affect dendritic
cell function.
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INTRODUCTION
Reactive oxygen species (ROS) are a key component of the innate
immune response, mostly in the neutrophil oxidative burst (1).
When neutrophils, macrophages or dendritic cells phagocytose
a pathogen, they rapidly activate the protein complex NOX2
(nicotinamide adenine dinucleotide phosphate oxidase 2) to
generate superoxide anions in the phagosomal lumen (2).
Activation is mediated by binding of the three cytosolic
components of NOX2 (p40phox, p47phox, and p67phox) and
the small-GTPase Rac1/2 with the two membrane components
(p22phox and gp91phox) (2). Superoxide anion can convert to
other species of ROS, such as the highly reactive hypochlorous
acid (HOCl) catalyzed by myeloperoxidase (MPO), which is
responsible for the killing of ingested pathogens (3, 4). Because
of the oxidative damage inflicted by bursts of ROS production,
neutrophils usually die together with the ingested pathogen and
are subsequently cleared by macrophages. It is estimated that
superoxide generation in neutrophils can reach rates as high
as 5 mM/s per phagosome for the duration of 10–15min and
then these rates rapidly decline within 30min (5–8). Similarly, in
macrophages the oxidative burst lasts for∼30min after pathogen
uptake (9).
In contrast, dendritic cells of the adaptive immune system
exhibit prolonged ROS production, which plays a key role
not only in the killing of ingested pathogens (10), but also
in antigen presentation and cross-presentation (11, 12). Cross-
presentation is the presentation of peptides derived from ingested
antigens on major histocompatibility complex class I (MHC-
I), which is normally restricted to endogenous peptides (13,
14). This process is essential for building cytolytic T cell
immune responses to intracellular pathogens, certain viruses and
various forms of cancer (15, 16). In order for antigens to be
presented on MHC-I, they need to be preserved and allowed
to leave the phagosome. Three mechanisms are described by
which NOX2 promotes antigen cross-presentation. First, the
dismutation of superoxide anion to hydrogen peroxide consumes
protons that leads to alkalization of the endo/phagosomal lumen,
which counteracts the V-ATPase, inhibits activation of lysosomal
hydrolases with low pH-optima and thus preserves antigen
for cross-presentation (11, 12, 17–19). Second, we previously
showed that the ROS produced by NOX2 can oxidize lipids of
the endo/phagosomal membrane leading to leakage of antigen
from the lumen into the cytosol where it can enter the MHC-
I pathway (20, 21). Finally, cysteine residues located in the
catalytic core of certain cathepsin proteases can be oxidatively
modified, which also prevents excessive degradation of antigen
(22, 23). The last mechanism also alters the epitopes generated for
presentation on MHC-II to helper T cells (24). The intracellular
pathogen Leishmania evades host immunity by inhibiting antigen
cross-presentation through disruption of NOX2 delivery to
pathogen containing phagosomes (19). Since the process of
antigen cross-presentation in dendritic cells is a much subtler
process than that of pathogen elimination in neutrophils, lower
ROS production rates can be expected, yet quantifications of
ROS production rates in the phagosomes of dendritic cells
are lacking.
Most ROS measurements rely on probes that change
fluorescence upon oxidation, such as Amplex Red, H2DCFDA,
or ADPA. Unfortunately, most, if not all, of these compounds
are only responsive to certain ROS (25). However, most ROS
can rapidly convert to various species, such as dismutation of
superoxide anion to hydrogen peroxide and hydroxyl anion by
Fenton chemistry. Moreover, as ROS are unstable, they are short-
lived and readily react with proteins, lipids and nucleic acids
(26), making quantitative detection by ROS-sensitive probes
impossible. However, since the production of superoxide anion
by NOX2 consumes oxygen in a 1:1 ratio, an increase in oxygen
consumption rate (OCR) during the oxidative burst directly
reflects the rate at which superoxide anion is produced (8).
In this paper, we measured OCRs in the culture medium of
human monocyte-derived dendritic cells in real time. These
cells are derived from blood-circulating monocytes, and capable
of both MHC-II presentation and MHC-I cross-presentation.
Monocyte-derived dendritic cells are positive for dendritic cell
markers CD11b, CD11c, CD14, HLA-DR, CD83, and CD86,
and negative for monocyte and macrophage markers CD16 and
CD68 (27), and, although their physiological role is unclear,
they likely represent an inflammatory type of dendritic cell.
Monocyte-derived dendritic cells were pulsed with opsonized
zymosan particles, which are relatively monodisperse ∼4 µm-
sized yeast cell wall fractions that are readily ingested by
phagocytosis, triggering NOX2 activity (20, 21, 28). Combined
with quantitative microscopy, this allowed us to estimate the rate
and duration of ROS production inside the zymosan-containing
phagosomes of these dendritic cells.
RESULTS
We first determined the time needed for the assembly of
NOX2 following phagocytosis. Both the membrane component
gp91phox and the cytosolic component p67phox, which is one of
the last components to be added to the NOX2 complex for its
assembly (29), were visualized by immunofluorescence labeling.
A confocal microscopy time-series of zymosan incubation
showed that these subunits already overlapped at the phagosomal
membrane after 5min (i.e., the earliest timepoint sampled
after zymosan addition), confirming the rapid assembly of the
NOX2 complex at phagosomes (Figure 1A). To assess whether
NOX2 was assembled already at the nascent cup of emerging
phagosomes, we also performed microscopy experiments with
fluorescein isothiocyanate (FITC)-conjugated zymosan particles.
Following incubation, we fixed the cells and stained with an anti-
FITC antibody before permeabilization, as described earlier (30).
This allowed us to visualize nascent cups, as the FITC staining
is only present on zymosan particles that are not yet completely
internalized. We observed assembly of NOX2 (i.e., the presence
of gp91phox and p67phox) already before closure of the phagocytic
cup (Figures 1B–E), indicating that NOX2 is activated rapidly
upon encountering a pathogen. In line with this, we also observed
the presence of gp91phox on ∼75% of phagosomes positive for
the early endosomal marker EEA1 (Supplemental Figure 1).
These findings corroborate our previous findings that gp91phox
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FIGURE 1 | NOX2 assembly at the phagocytic cup in monocyte-derived dendritic cells. (A) Representative confocal micrograph of a cell pulsed for 5min with Alexa
Fluor 633-labeled zymosan (magenta in merge) and immunostained for gp91phox (cyan), p67phox (yellow), and DAPI (blue). Scale bar: 2µm. Graph: fluorescence
intensity cross-sections over zymosan particles for multiple phagosomes. The bold cross-sections are from the left-hand images (indicated with the dotted line).
Twenty-one phagosomes from 3 donors were analyzed. (B) Representative confocal micrograph of cell pulsed with FITC-labeled zymosan (magenta in merge) and
immunostained for anti-FITC (in absence of permeabilization; yellow), p67phox (with permeabilization; cyan) and DAPI (blue). Yellow arrow head: phagocytic cup. White
arrow head: closed phagosome. Note the localization of p67phox at the phagocytic cup. Scale bar: 2µm. Twenty-nine phagosomes from 15 cells and 3 donors were
analyzed. (C) Same as (B), but for gp91phox (cyan). Scale bar: 2µm. Thirty phagosomes from 16 cells and 3 donors were analyzed. (D) Mean fluorescent intensity
(MFI) of p67phox in the phagosome compared to the cytosol after 5min of zymosan stimulation (as shown in B). Three donors were analyzed, each dot represents a
single cell. p < 0.0001; paired Student’s t-test. (E) Same as panel (D), but now for gp91phox as in panel (C). p < 0.0001; paired Student’s t-test. (F) Representative
live cell epi-fluorescence imaging of a cell pulsed with zymosan labeled with both Alexa Fluor 633 (magenta) and nitrotetrazolium blue chloride (NBT) (transmission
channel). Oxidation of NBT results in formation of dark formazan crystals (yellow arrow heads). Scale bar: 4µm. Video file in Supplementary Movie 1. (G)
Quantification of NBT crystal formation before and 25min after attachment of a zymosan particle for six different donors (see also Supplementary Data 1). p =
0.009; paired Student’s t-test. **p < 0.01; ***p < 0.001.
is recruited to nascent phagosomes from the plasma membrane
(21, 28).
To obtain insight in the time scale of ROS production
following zymosan uptake, we stimulated dendritic cells with
fluorescently labeled zymosan together with nitrotetrazolium
blue chloride (NBT). NBT forms insoluble formazan crystals
upon oxidation and this can be visualized as dark deposits in
the transmission channel during live cell imaging. We observed
crystal formation within 2min after attachment of a zymosan
particle to a dendritic cell (Figure 1F; Supplementary Movie 1).
This process continued for at least 25min, after which most NBT
was converted to formazan (Figure 1G). Together, these results
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show that NOX2 is assembled already at the nascent cup of
emerging phagosomes and ROS production occurs rapidly (i.e.,
within minutes) after zymosan attachment.
Zymosan is a potent inducer of NOX2 activation (20, 21, 28)
as it activates signaling of a number of pattern recognition
receptors, including Toll-like receptor 2 (TLR2) and the C-
type lectin Dectin-1 (31). Indeed, Amplex Red measurements
showed that zymosan evoked the highest ROS production by
monocyte-derived dendritic cells when compared to the soluble
TLR agonist lipopolysaccharide (LPS; TLR4), ovalbumin (binds
to the C-type lectin CD206) and to the other phagocytic cargoes
PAM3CSK4-coated beads (TLR2) and depleted zymosan (only
Dectin-1) (Figure 2A). In these experiments, the cells were all
stimulated with the same amount of five particles per cell for
the phagocytic cargoes: zymosan, PAM3CSK4-coated latex beads,
depleted zymosan, and naked latex beads (negative control).
For the soluble ligands LPS and ovalbumin, we could not
directly relate their concentrations to that of large phagocytic
particles and used final concentrations of 1µg/ml for LPS and
2.5µg/ml for ovalbumin. We also compared ROS production
of human monocyte-derived dendritic cells with the murine cell
lines JAWS-II and RAW264.7 using the intracellular fluorescent
ROS probe H2DCFDA (32). JAWS-II is an immortalized cell
line from mouse bone marrow and is a frequently used model
system for dendritic cell function capable of phagocytosis and
antigen presentation. RAW264.7 is derived from a murine
tumor and is a frequently used model system for macrophages.
Compared tomonocyte-derived dendritic cells, zymosan resulted
in ∼40% less ROS production in RAW264.7 cells, whereas
zymosan hardly induced any ROS production in JAWS-II cells
(Supplemental Figure 2).
Next, we investigated the duration of ROS production to
obtain an estimate of the total amount of ROS produced by
human monocyte-derived dendritic cells. The duration of ROS
production cannot be determined with OCR measurements,
because in a closed chamber the amount of oxygen is limited,
resulting in complete depletion of oxygen, whereas in an open
chamber the oxygen levels are also influenced by an ingress
of oxygen diffusion from the atmosphere which is difficult
to quantify. We therefore measured ROS production of the
monocyte-derived dendritic cells with H2DCFDA (32). Although
this probe does not allow quantitative measurements of ROS
levels, it does allow qualitative monitoring of ROS production
for extended periods of time after stimulation with zymosan.
ROS production was still observed at least 10 h post zymosan
stimulation (Figure 2B). At later time points, the fluorescence
increase of H2DCFDA in the zymosan exposed cells was similar
to the non-stimulated control, indicating that zymosan-evoked
ROS production had stopped. Flow cytometry measurements
using the fixable viability marker Zombie Violet showed that
about ∼10% of the dendritic cells died during the first 10 h of
zymosan incubation, whereas cell viability was not affected in
absence of zymosan (Supplemental Figure 3).
Finally, to determine the OCRs during zymosan uptake, we
measured real-time oxygen concentrations in the medium using
a fiber optic sensor connected to a Fibox 3 LCD trace fiber-
optic oxygen meter calibrated to 37◦C. These measurements
were done in a closed 1ml chamber containing 1·106 monocyte-
derived dendritic cells. After reaching a stable baseline OCR,
we added zymosan at a ratio of five particles/cell, triggering
phagocytic uptake and ROS production. This caused an
average OCR increase from 28 to 88 amol (1·10−18)/cell/second
(Figures 2C,D), although there was a large variation among
donors. This large variation in ROS production within the
human population, which is likely due to genetic and life
style differences, has been reported before (11) and is well-
known for other immunological readouts such as cytokine
secretion. Compared to monocyte-derived dendritic cells, a more
than 10-fold higher rate of oxygen consumption was found
in blood-isolated neutrophils following zymosan addition using
the same methodology (Figure 2E; 1,059 amol/cell/s), which is
in line with previous reports (5–7). To account for potential
upregulation of cell metabolism following zymosan stimulation,
we also treated monocyte-derived dendritic cells with the
respiratory chain complex I inhibitor rotenone, which blocks
oxidative phosphorylation (33). We found that the increase in
OCR following zymosan addition was comparable to cells not
treated with rotenone (Figure 2F; from 4 to 67 amol/cell/s).
Conversely, inhibition of the pentose phosphate pathway using
6-aminonicotinamide (6-AN), which blocks generation of the
NOX2 substrate NAD(P)H, completely abrogated zymosan-
induced oxygen consumption (Figure 2G). These findings
confirm the well-known role of NOX2 in TLR-evoked ROS
production in human monocyte-derived dendritic cells (10, 11,
20, 21).
These results indicate that on average 60 amol
superoxide/cell/s was produced following zymosan addition.
As quantitative microscopy showed that ∼3 zymosan particles
were ingested per cell (Figure 2H), this means that ∼20 amol/s
of superoxide anion is produced per phagosome. Because
most zymosan particles are ∼40 µm3 in size (or ∼40 fL)
(Figure 2I), the average net superoxide anion production rate is
approximately 0.5 mM/s within the phagosome. Combined with
our estimation of the duration of ROS production by H2DCFDA
measurements (Figure 2B), we estimate that the total amount of
superoxide anion produced is ∼720 fmol/phagosome, or about
4.2·1011 molecules/phagosome. Again, due to the large variation
in phagocytic uptake among cells and oxygen consumption
among donors (11), this number is only a coarse estimate and is
expected to vary widely among cells and donors.
DISCUSSION
In this study, we estimated the production of ROS by NOX2 in
zymosan-containing phagosomes of human monocyte-derived
dendritic cells. By subtracting baseline oxygen consumption from
total cellular oxygen consumption following zymosan addition,
we estimate a ROS production of ∼0.5 mM/phagosome/s. This
estimate is based on the assumption that the majority of ROS is
produced within phagosomes as supported by our finding that
assembled NOX2 is mostly located at phagosomes. Moreover, we
found that monocyte-derived dendritic cells assemble the NOX2
complex already at the nascent cup of phagosomes, allowing
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FIGURE 2 | Determination of the oxygen consumption rate (OCR) of monocyte-derived dendritic cells following zymosan exposure. (A) ROS production by
monocyte-derived dendritic cells exposed to a range of phagocytic cargoes and soluble TLR stimuli as determined by Amplex Red fluorescence. MFI: mean
fluorescence intensity. Shown is the average of three donors ± SEM. The table shows results from linear regression analysis on the integrated curves (***p < 0.001;
**p < 0.005; *p < 0.01). (B) ROS production by zymosan-exposed monocyte-derived dendritic cells as determined by H2DCFDA fluorescence. Shown is the average
of three donors ± SEM. p < 0.0001; linear regression analysis on the integrated curves. (C) Temporal decline in oxygen levels in the culture medium before and after
stimulation with zymosan in a closed container of a representative donor. (D) Difference in OCR of monocyte-derived dendritic cells before and after stimulation with
zymosan in a closed container. Each data point presents an individual donor (n = 9). p = 0.0005; paired Student’s t-test. (E) Same as panel (D), but with neutrophils
(n = 3). p = 0.0143; paired Student’s t-test. (F) Difference in OCR in monocyte-derived dendritic cells before and after stimulation with zymosan with simultaneous
addition of the mitochondrial complex I inhibitor Rotenone (n = 3). p = 0.0256; paired Student’s t-test. (G) Difference in OCR before and after stimulation with
zymosan in a closed container in cells pre-incubated for 1 h with the glucose-6-phosphate dehydrogenase inhibitor 6-aminonicotinamide (6-AN) (n = 3). p = 0.9868;
paired Student’s t-test. (H) Frequency distribution of the number of zymosan particles taken up by monocyte-derived dendritic cells following 30min exposure to
zymosan (99 cells pooled for three different donors; bin size: 1 particle). Insert: Representative epi-fluorescence microscopy image of a cell with phagocytosed Alexa
Fluor 633-labeled zymosan (magenta). Scale bar: 10µm (I) Frequency distribution of the volume of zymosan particles from microscopy (521 zymosan particles in
total; bin size: 5 µm3 ). (J) Model figure of NOX2 activity during phagocytosis by monocyte-derived dendritic cells. NOX2 is already assembled and active before
closure of the phagocytic cup and remains active on the phagosomal membrane for on average at least 10 h. NOX2-mediated conversion of oxygen (O2) to
superoxide anion (O•−2 ) results in a production rate of ROS of approximately 0.5 mM/s.
them to generate ROS within minutes upon encountering
a pathogen, similar to neutrophils and macrophages (6)
(Figure 2J). The presence of NOX2 already at the phagocytic
cup is in line with observations from our (28, 34) and other
(11) laboratories that NOX2 is assembled during phagosome
formation, remains present during the early phase of phagosomal
maturation (early markers EEA1 and phosphatidylinositol 3-
phosphate) and is removed from phagosomes upon maturation
to the late LAMP1 and V-ATPase positive stage. Unfortunately,
direct quantitative measurements of ROS within the lumen of
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phagosomes are not technically feasible at present, but since our
microscopy showed that assembled NOX2 was mainly present at
phagosomal membranes, we consider our assumption that the
majority of ROS is produced within phagosomes justified. Our
estimated ROS production of ∼0.5 mM/phagosome/s should be
regarded as a coarse estimate, since there is large variation in
terms of phagocytic activity and oxygen consumption among
individual cells as well as between different donors [see also (11)].
In addition, our ROS measurements show that these numbers
differ depending on the TLRs that are stimulated (Figure 2A).
Nevertheless, despite being a coarse estimate, our results provide
at least an order of magnitude of the ROS production in
monocyte-derived dendritic cells.
Our data show that the ROS production in phagosomes of
monocyte-derived dendritic cells is about an order of magnitude
lower than the 5 mM/phagosome/s estimated for neutrophils (5–
7). However, we found that ROS production in dendritic cells
is sustained for ∼10 h after uptake, which is at least an order
of magnitude longer than in neutrophils and macrophages (5–
7, 9). This means that although dendritic cells produce ROS
at a lower rate, the cumulative ROS production over time in
dendritic cells and neutrophils could be approximately similar.
The viability of dendritic cells in this time frame is not much
affected as ∼90% of zymosan-pulsed cells survive. As noted
in the introduction, both the lower, sustained ROS production
and the maintained viability likely relate to the unique immune
function of dendritic cells by promoting ROS-mediated MHC-I
antigen cross-presentation to cytolytic T cells (11, 12, 17–23) and
modulating the epitope repertoire for MHC-II presentation to
helper T cells (24). The reduced activation of lysosomal proteases
by ROS (12, 17, 18, 22, 23) could also allow the antigen to be
preserved for the time that the dendritic cell needs to travel from
a site of infection to the nearest lymph node to present antigen
to T cells (35). The comparatively low but prolonged activity of
NOX2 and their prolonged viability therefore directly contribute
to the antigen presenting capacity of dendritic cells.
Given the role of phagosomal ROS in antigen presentation
(11, 12, 17–24), it would be interesting to measure ROS
production by the three major types of dendritic cells found in
human peripheral blood: plasmacytoid dendritic cells and CD1c
and CD141 positive myeloid dendritic cells (36). Plasmacytoid
dendritic cells produce large amounts of type I interferons
in response to microbial or viral infections and are key
effectors of innate immunity and helper and cytolytic T
cell priming (37). Both CD1c and CD141 positive myeloid
dendritic cells can produce large amount of interleukin-12 to
promote Th1 responses and cytolytic T cell priming. Both
these myeloid dendritic cell subsets can also cross-present
exogenous antigens to prime naive cytolytic T cells (38–43). It
will also be interesting to measure ROS production by monocyte-
derived macrophages, which, although their ROS production
is lower compared to dendritic cells (11), are also capable of
cross-presentation (44).
Next to antigen presentation, a second effect of NOX2
activity is metabolic reprogramming caused by the rapid
consumption of both NADPH and oxygen (45, 46). An
oxidative cellular redox state influences metabolism, and via
this way promotes for example monocyte differentiation into
pro-inflammatory effector cells (47). Moreover, ROS and its
derivatives, particularly hydrogen peroxide and lipid aldehydes,
are able to traverse membranes and signal inflammation in
neighboring cells (48, 49). Thereby, ROS can amplify the
inflammatory immune response, leading to production of more
ROS. Thus, ROS have important functions in both innate and
adaptive immune responses and having quantitative information
on ROS generation is crucial for understanding dendritic cell
function (45).
METHODS
Cells
Dendritic cells were derived from human peripheral blood
mononuclear cells (PBMCs) by IL-4 and GM-CSF as described
previously (35). Neutrophils were isolated from heparinized
venous blood by Ficoll-Histopaque (Sigma Aldrich, St. Louis,
USA) density gradient centrifugation followed by hypotonic
erythrocyte lysis (50). Buffy coats and whole blood were
obtained as anonymous coded specimens from the Dutch
blood bank (Sanquin) and were handled according to known
practice and legal guidelines. The research with human blood
samples at the Department of Tumor Immunology complies
with all institutional and national ethics regulations and
has been approved by the ethics committee of Sanquin. All
blood donors were informed of the research and have granted
their consent. The age range of the donors was between 30
and 60 years. For OCR measurements, cells were cultured
in phenol-red free RPMI-1640 (Thermo Fisher Scientific,
Waltham, USA). JAWS-II (American Type Culture Collection
(ATCC), CRl-11904) were cultured in MEM Alpha (Thermo
Fisher Scientific) supplemented with 20% FBS (Greiner Bio-
one, Kremsmünster, Austria), 5mM UltraGlutamine (Lonza,
Basel, Switzerland), 1mM sodium pyruvate (Thermo Fisher
Scientific), 0.05mM 2-mercaptoethanol, 10 ng/ml recombinant
mouse GM-CSF, and 1% antibiotic-antimycotic (Thermo Fisher
Scientific). RAW264.7 (ATCC, TIV-71) cells were cultured
in Dulbecco’s Modified Eagle Medium (DMEM) (Thermo
Fisher) supplemented with 10% FBS (Greiner Bio-one),
2mM UltraGlutamine (Lonza), and 1% antibiotic-antimycotic
(Thermo Fisher Scientific). Cells were stimulated with zymosan
A (from Saccharomyces cerevisiae, Sigma-Aldrich, St. Louis,
USA; five particles/cell), LPS (Lipopolysaccharides from
Escherichia coli O111:B4; Sigma Aldrich; final concentration
of 1µg/ml), PAM3CSK4 (InvivoGen, Toulouse, France) coated
latex beads (five beads/cell), depleted zymosan (InvivoGen;
five particles/cell), naked latex beads (five beads/cell), soluble
ovalbumin (final concentration of 2.5µg/ml; Endofit ovalbumin,
InvivoGen) or Alexa Fluor 633-labeled zymosan A in serum-free
RPMI-1640 (five particles/cell). To inhibit NOX2 activity by
blocking generation of NAD(P)H, cells were pre-incubated
for 1 h with 10µM 6-aminonicotinamide (Sigma Aldrich). To
inhibit mitochondrial respiration by inhibition of respiratory
complex I, rotenone (Sigma Aldrich) was added simultaneously
with the zymosan stimulus to a final concentration of 500 nM.
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H2DCFDA Measurements
Cells were loaded for 10min with 10µg/ml 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA, Thermo
Fisher Scientific) in DMSO, stimulated with five particles/cell
of zymosan and fluorescence (ex: 485/20, em: 530/30) was
measured using a CytoFluor II microplate reader (Thermo
Fischer Scientific). Background fluorescence was subtracted
from all measurements.
Amplex Red Measurements
Fifty thousand monocyte-derived dendritic cells were
stimulated with the stimuli specified above and plated in
individual wells of a clear flat-bottom 96-wells plate. Cells
were subsequently incubated for 1 h at room temperature.
After incubation, supernatant was removed and cells were
washed once with phosphate-buffered saline (PBS). Fifty
microliter Amplex Red (Thermo Fisher Scientific) mix
(25µM Amplex Red and 0.1U HRP in phosphate-buffered
saline) was added to each well. Amplex Red fluorescence was
measured every 10min using a CytoFluor II microplate
reader (excitation: 530/25, emission: 590/35) (Thermo
Fisher Scientific).
Microscopy
Live cell imaging was performed on a Leica DMI-6000B
inverted epi-fluorescence microscope using a Leica HCX PL
APO 40x/0.85 objective. NOX2 assembly was imaged on a
Leica SP8 confocal using a Leica HC PL APO CS2 63x/1.2
water immersion objective. For immunofluorescence, cells
were fixed with 4% paraformaldehyde in PBS for 20min, then
permeabilized with 0.1% saponin in PBS. NOX2 subunits were
stained using the following antibodies: mouse monoclonal
IgG1 anti-CYBB (1:200; D162-3 MBL International, Woburn,
USA), rabbit polyclonal IgG anti-gp91 (1:100; ab180642
Abcam, Cambridge, UK) and rabbit polyclonal IgG anti-p67
(1:500; 07-002 Millipore-Sigma, Burlington, MA, USA).
EEA1 was stained with mouse monoclonal IgG1 anti-
EEA1 (1:100; 610456 BD Biosciences, San Jose, CA, USA).
Coverslips were mounted in mounting medium containing
0.01% Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid) and 68% glycerol in 200mM sodium
phosphate buffer at pH 7.5 with 0.1µg/ml DAPI. Recruitment
of NOX2 subunits gp91phox and p67phox was quantified by
comparing fluorescent intensities in the cytosolic regions to
phagosomal membrane regions selected by thresholding for
fluorescent zymosan particles partially or completely negative
for FITC.
NBT Assay
Cells were incubated with 12µg/ml NBT (Hoffmann-La Roche,
Rish-Rotkreuz, Switzerland) in Live Cell Imaging Solution
(Thermo Fisher Scientific) and stimulated with Alexa Fluor
633-labeled Zymosan A (five particles/cell). Formazan crystal
formationwas quantified in regions of interest by thresholding on
the fluorescence of the zymosan particles using a custom imageJ
script (Supplementary Data 1) and measuring the intensities of
these regions of interest in the bright-field channel. As NBT
crystals are dark, pixel intensity decreases upon formation of
NBT crystals and we normalized all values to those measured in
the first frame.
OCR Measurements
The OCR during zymosan uptake was measured with 1·106
cells in a closed 1ml chamber, using a fiber optic trace
oxygen meter (PreSens Precision Sensing, Regensburg,
Germany) with an Oxygen Sensor Spot (PreSens) placed
inside. Measurement conditions were 37◦C and 1 atm. Upon
reaching a steady baseline OCR, 5 zymosan particles/cell were
added by injection.
Viability Assay
Cells were washed with PBS and incubated for 30min with
Zombie Violet fixable viability dye (1:2000 in PBS) (BioLegend,
San Diego, CA, USA) in a V-bottom 96-well plate at 100,000
cells per well. Cells were then washed and fixed for 5min in 4%
paraformaldehyde in PBS and analyzed on a FACS Lyric flow
cytometer (BD Biosciences).
Statistical Analysis
Paired Student’s t-tests were applied to assess significance,
unless indicated otherwise. For multiple comparisons, a repeated
measures ANOVA with Bonferroni post-hoc testing was applied.
For the H2DCFDA time course experiments and the comparison
between various TLR stimuli, we integrated the curves and
compared the slopes using linear regression analysis in Graphpad
Prism 5.
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Supplementary Movie 1 | Time-lapse microscopy of a monocyte-derived
dendritic cell (bright-field) taking up a fluorescently labeled zymosan particle
(magenta). Deposition of formazan crystals by oxidation of NBT can be observed
as dark spots in the bright-field channel. Timestamp in minutes:seconds.
Supplementary Data 1 | ImageJ script used for analysis of formazan crystal
formation.
Supplemental Figure 1 | gp91phox is present on EEA1-positive phagosomes.
Representative confocal micrograph of monocyte-derived dendritic cell pulsed
with Alexa fluor 633-labeled zymosan (magenta in merge) for 5min and
immunostained for gp91phox (cyan) and EEA1 (yellow). Arrowhead indicates a
phagosome. The graph shows EEA1-positive phagosomes that were blindly
assessed manually as positive or negative for gp91phox (n = 3, at least 40
phagosomes per donor). p = 0.0207; paired Student’s t-test. ∗p < 0.05.
Supplemental Figure 2 | ROS production by mouse phagocytic cell lines. Time
course experiments following stimulation with 5 zymosan particles per cell. ROS
production was measured by H2DCFDA fluorescence in human
monocyte-derived dendritic cells, mouse RAW264.7 macrophages, and
mouse JAWS-II dendritic cells. MFI, mean fluorescence intensity
(n = 3 ± SEM).
Supplemental Figure 3 | Viability of monocyte-derived dendritic cells
stimulated with zymosan for 48 h. Representative dot plots showing forward
scatter vs. Zombie Violet fluorescence intensity of monocyte-derived dendritic
cells incubated with 5 zymosan particles per cell for the indicated durations.
Smaller dot plots show back gating of lymphocyte population gate based on
forward and side scatter. The scatter plot shows percentages of Zombie Violet
positive cells for the indicated time points (n = 3). Repeated measures ANOVA
with Bonferroni post-hoc testing (∗∗p < 0.005; ∗p < 0.05).
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